MedZERO Offers Buy Now, Pay Later Solution for Out-of-Pocket Medical Costs

Retrieved on: 
Friday, December 10, 2021

MedZERO is an employer-sponsored "Buy Now, Pay Later" solution for employees that ensures out-of-pocket medical costs can become manageable payments, made over time - with zero interest and zero fees - through simple payroll deduction.

Key Points: 
  • MedZERO is an employer-sponsored "Buy Now, Pay Later" solution for employees that ensures out-of-pocket medical costs can become manageable payments, made over time - with zero interest and zero fees - through simple payroll deduction.
  • The burden on patients is expected to grow amid the increasing reliance on high-deductible medical plans and the overall rising costs of healthcare.
  • "The status quo is unsustainable as the entire system is negatively impacted," said Craig Froude, medZERO CEO and co-founder.
  • MedZERO has created a leading Buy Now, Pay Later platform offered by employers that turns large out-of-pocket costs into manageable payments, made over time, through payroll deduction - atZERO interestandwith ZERO fees for their employees.

ACAMS, World Wide Fund for Nature and Wildlife Justice Commission Launch Training for Law Enforcement Officials Investigating Wildlife Trafficking

Retrieved on: 
Friday, December 10, 2021

Successful applicants must complete one hour of self-study in addition to completing five questions, under the program.

Key Points: 
  • Successful applicants must complete one hour of self-study in addition to completing five questions, under the program.
  • Given the role that wildlife trafficking plays in fueling corruption, undermining the global financial sector, and reducing the planets biodiversity, this is a fight that cant be ignored, said Liles.
  • This initiative marks an important step towards applying the most relevant techniques and methodologies for investigating criminal networks trafficking wildlife.
  • Adtalem was named one of Americas Most Responsible Companies 2021 by Newsweek and one of Americas Best Employers for Diversity 2021 by Forbes.

HUTCHMED Highlights Surufatinib and Toripalimab Combination Clinical Data being Presented at the ESMO Immuno-Oncology 2021 Meeting

Retrieved on: 
Friday, December 10, 2021

The approval was based on results from the SANET-ep study, a Phase III trial (clinicaltrials.gov identifier: NCT02588170 ) in patients with advanced epNETs conducted in China.

Key Points: 
  • The approval was based on results from the SANET-ep study, a Phase III trial (clinicaltrials.gov identifier: NCT02588170 ) in patients with advanced epNETs conducted in China.
  • The study met the pre-defined primary endpoint of PFS at a preplanned interim analysis, and was published in The Lancet Oncology1.
  • Pancreatic Neuroendocrine Tumors (pNETs) in China: On June 16, 2021, surufatinib was granted drug registration approval by the NMPA for the treatment of pNET.
  • Earlier, the FDA granted 2 Breakthrough Therapy designations, 1 Fast Track designation, 4 Orphan Drug designations for toripalimab.

First subject dosed in phase I clinical study with eye-drop formulation of laquinimod  

Retrieved on: 
Friday, December 10, 2021

Lund, December 10, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the first subject has been dosed in the phase I clinical study of the newly developed eye-drop formulation of the companys candidate drug laquinimod.

Key Points: 
  • Lund, December 10, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the first subject has been dosed in the phase I clinical study of the newly developed eye-drop formulation of the companys candidate drug laquinimod.
  • A preclinical program shows that the laquinimod eye-drop is safe and well tolerated, and the safety of this new formulation will now be tested in a phase I clinical study in healthy subjects.
  • The primary endpoint of the study is to determine the safety and tolerability of laquinimod eye-drops after single and repeat doses.
  • Laquinimod is advancing to a clinical phase I study with a topical ophthalmic formulation, to be followed by phase II for treatment of non-infectious uveitis.

Pegasus Entrepreneurs announces successful upsized €210 million private placement and admission to listing on Euronext Amsterdam

Retrieved on: 
Friday, December 10, 2021

AMSTERDAM, The Netherlands, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Pegasus Entrepreneurial Acquisition Company Europe B.V. (“Pegasus Entrepreneurs”), the newly formed Special Purpose Acquisition Company (SPAC) focussed on European growth companies and backed by serial entrepreneur Pierre Cuilleret and institutional sponsors Tikehau Capital SCA (“Tikehau Capital”) and Financière Agache SA (“Financière Agache”), today announces that it has successfully raised €210 million in the Offering (as defined below). The Offering was upsized by €10,000,000 due to strong investor demand.

Key Points: 
  • This announcement is not for publication or distribution, directly or indirectly, in or into the United States.
  • This announcement is not an offer of securities for sale into the United States.
  • The Company will not be registered in the United States as an investment company under the U.S. Investment Company Act of 1940.
  • Copies of the prospectus may be obtained at no cost from the Company or through the website of the Company.

Boris Johnson, S. Jaishankar, Nivruti Rai, and More to Speak at Carnegie India's 2021 Global Technology Summit

Retrieved on: 
Friday, December 10, 2021

NEW DELHI, India, Dec. 10, 2021 (GLOBE NEWSWIRE) -- From December 14-16, 2021, Carnegie India will co-host the 6th edition of its annual flagship event, the Global Technology Summit (GTS) with the Ministry of External Affairs, Government of India, themed Global Meets Local.

Key Points: 
  • NEW DELHI, India, Dec. 10, 2021 (GLOBE NEWSWIRE) -- From December 14-16, 2021, Carnegie India will co-host the 6th edition of its annual flagship event, the Global Technology Summit (GTS) with the Ministry of External Affairs, Government of India, themed Global Meets Local.
  • All the conversations happening at the Summit can be accessed free of cost by registering on GTS2021.COM .
  • Join the conversation on social media with # GlobalTechSummit and follow Carnegie India on Twitter @ CarnegieIndia .
  • The Carnegie Endowment for International Peace is a nonpartisan foreign policy think tank with centers in Washington, D.C., Moscow, Beirut, Beijing, Brussels, and New Delhi.

ObsEva Hosts Symposium and Presents Clinical Data on Oral GnRH Antagonist Linzagolix at SEUD Congress 2021

Retrieved on: 
Friday, December 10, 2021

Linzagolix is a novel, once daily, oral GnRH receptor antagonist with a potentially best-in-class profile1,2,3.

Key Points: 
  • Linzagolix is a novel, once daily, oral GnRH receptor antagonist with a potentially best-in-class profile1,2,3.
  • Obseva licensed linzagolix from Kissei in late 2015 and retains worldwide commercial rights, excluding Asia, for the product.
  • The primary efficacy endpoint was reduced MBL at 24 weeks (MBL 80 mL and 50% reduction from baseline).
  • Patients were randomized to receive either an oral once daily dose of linzagolix (50mg, 75mg, 100mg or 200mg) or placebo for up 12 weeks.

Announcing the Creation of LIFE CALLING INITIATIVE

Retrieved on: 
Friday, December 10, 2021

NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The Life Calling Initiative was announced today in New York City, founded by John Mack.

Key Points: 
  • NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The Life Calling Initiative was announced today in New York City, founded by John Mack.
  • The newly established Life Calling Initiative explores this nexus of new technology and human behavior.
  • It is the overarching aspiration of the Life Calling Initiative to help members of society live fulfilled lives in the digital age while retaining their humanity and personal autonomy.
  • Among the initial projects of the Life Calling Initiative is a month-long interactive immersive exhibition of artworks by John Mack in New York City in May 2022.

New Partnership Formed to Develop an NFT Marketplace for Hotel Stays, and Travel-Related Products

Retrieved on: 
Friday, December 10, 2021

This is exactly what this joint partnership will deliver: by tokenizing each hotel night, airbnb's type of rental houses, and travel-related products via NFT, and allowing the trading of these tokens on the marketplace built on blockchain.

Key Points: 
  • This is exactly what this joint partnership will deliver: by tokenizing each hotel night, airbnb's type of rental houses, and travel-related products via NFT, and allowing the trading of these tokens on the marketplace built on blockchain.
  • Travelers who cannot make it to a hotel or airbnb's rentals to use their booking can re-sell their NFT tokens on the marketplace to recover the cost or even to make a profit.
  • Travel companies or retail investors can book hotel rooms in advance at a cheap rate, and re-sell them to those who need them for a profit.
  • This flexibility, along with a loyalty program run on Beowulf's boyoty.com and defiato.com exchange, will bring true value to travelers on a global scale.

WPFH Announces Acquisition of KPOP 1004 Retail Chain

Retrieved on: 
Thursday, December 9, 2021

LOS ANGELES, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- World Poker Fund Holdings, Inc. (OTC PINK: WPFH), announces today that it has signed a definitive agreement to acquire Kimco Industries Inc., the owner and operator of the retail chain KPOP 1004, a K-POP and K-Beauty specialty store.

Key Points: 
  • LOS ANGELES, CA, Dec. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- World Poker Fund Holdings, Inc. (OTC PINK: WPFH), announces today that it has signed a definitive agreement to acquire Kimco Industries Inc., the owner and operator of the retail chain KPOP 1004, a K-POP and K-Beauty specialty store.
  • KPOP 1004 stores are currently located in the Ontario Mills Shopping Center of Ontario, CA; Westfield Valencia Town Center of Valencia, CA; and the Premium Outlets of Las Vegas, NV.
  • As part of the acquisition agreement, WPFH will be changing its name to KPOP 1004, complete audits, and file a Form 10 registration statement with the SEC in preparation for OTCQB and KOSDAQ (the Korean Stock Exchange) up-listing and cross-listing.
  • KPOP, the Korean Wave (Hallyu) is the expansion of Korean culture, arts and media throughout the world.